Medicalgorithmics (B8E) Stock Overview

Provides cardiac diagnostic solutions in Poland, the United States, and internationally. More details

B8E fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	5/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Trading at 29% below our estimate of its fair value

Earnings are forecast to grow 89.37% per year

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap (€293M)

B8E Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Medicalgorithmics S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medicalgorithmics
Historical stock prices
Current Share Price	zł6.68
52 Week High	zł6.68
52 Week Low	zł6.68
Beta	0.75
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	B8E	DE Medical Equipment	DE Market
7D	n/a	-4.9%	-4.0%
1Y	n/a	-31.0%	-4.8%

Return vs Industry: Insufficient data to determine how B8E performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how B8E performed against the German Market.

Price Volatility

Is B8E's price volatile compared to industry and market?
B8E volatility
B8E Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	5.6%
Market Average Movement	6.0%
10% most volatile stocks in DE Market	13.9%
10% least volatile stocks in DE Market	2.6%

Stable Share Price: B8E's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine B8E's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2005	117	Kris Siemionow	www.medicalgorithmics.pl

Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. It offers PocketECG, an AI-driven online ECG monitoring device for long-term holter, cardiac event, and mobile cardiac telemetry analysis; Kardiobeat.ai, an AI-Driven lightweight wireless holter monitor; DeepRhythm Platform, a hardware-agnostic cloud-based software that leverages cutting-edge AI technology to detect, classify, analyze, and report ECG data; and DeepRhythmAI, a set of algorithms for heart rhythm analysis that integrates into third-party software and devices. The company also provides virtual cardiac stress test (VCAST), an AI-based medical system developed for non-invasive, clinical quantitative, and qualitative analysis of CT-scan data, to assess the hemodynamic significance of coronary artery atherosclerotic stenosis.

Medicalgorithmics S.A. Fundamentals Summary

How do Medicalgorithmics's earnings and revenue compare to its market cap?
B8E fundamental statistics
Market cap	€68.38m
Earnings (TTM)	-€3.59m
Revenue (TTM)	€6.26m

10.9x

P/S Ratio

-19.0x

P/E Ratio

Is B8E overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
B8E income statement (TTM)
Revenue	zł26.80m
Cost of Revenue	zł17.86m
Gross Profit	zł8.94m
Other Expenses	zł24.32m
Earnings	-zł15.38m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

Apr 28, 2026

Earnings per share (EPS)	-1.55
Gross Margin	33.36%
Net Profit Margin	-57.39%
Debt/Equity Ratio	27.2%

How did B8E perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/03/22 17:57
End of Day Share Price	2026/03/20 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medicalgorithmics S.A. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Adrian Kowollik	East Value Research GmbH
Lukasz Kosiarski	Ipopema Securities S.A.
Gabriela Burdach	Wood & Company